RAFAEL HOLDINGS, INC. Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest
RAFAEL HOLDINGS, INC. (RFL) reported Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest of -$37.00 thousand for the 12-month period ending 2021-07-31, per its 10-K filed 2021-10-18.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest · last filed 2021-10-18
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for fiscal 2021 was -$37.00K.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for fiscal 2020 was -$9.00K.
| Period end | Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2021-07-31 | -$37.00K 10-K · filed 2021-10-18 |
| 2020-07-31 | -$9.00K 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |